Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ThisCART22
i
Other names:
ThisCART22, ThisCART22 cells, allogeneic anti-CD22 CAR T cells
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Fundamenta Therap
Drug class:
CD22-targeted CAR-T immunotherapy, T lymphocyte replacement
Related drugs:
‹
CAR-T19/CAR-T22 immunotherapy (1)
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR (0)
4SCAR-T (0)
AUTO1/22 (0)
AUTO3 (0)
Anti-CD19/CD20/CD22 CAR T-Cells (0)
Anti-CD22 CAR-T Cells (0)
CAR-T CD19/CD20/CD22/CD30 (0)
CAR20.19.22 T (0)
CART-19/22 (0)
CART22 (0)
CART22 (0)
CD19 and CD22 targeted prime CAR-T (0)
CD19-CD22 CAR-T (0)
CD19/CD22 CAR T-cells (0)
CD19/CD22 CAR-T cell therapy (0)
CD19/CD22 chimeric antigen receptor T cell (0)
CD19/CD22 dual-target CAR-T (0)
CD19x22 CAR T (0)
CD22-CART (0)
CD22-targeted CAR-T cell therapy (0)
CD22/CD19 CAR T (0)
CT120 (0)
CTA101 (0)
GC022F (0)
HY004 (0)
IMJ995 (0)
JCAR018 (0)
LB1909 (0)
LCAR-AIO (0)
MB-CAR-T19-22 (0)
SCRI-CAR19x22v2 (0)
SCRI-CAR22v2 (0)
Senl_22 (0)
Senl_H19x22P (0)
UCART20x22 (0)
UCART22 (0)
anti-CD19/CD22 CAR-T cells (0)
anti-CD22 CAR T (0)
anti-CD22 CAR-T cell therapy (0)
anti-CD22 CAR-T therapy (0)
anti-CD22-CAR (0)
autologous TriCAR T (0)
CRG-022 (0)
multi-CAR-T cell therapy (0)
multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)
sequential different B cell antigen-targeted CAR T-cell therapy (0)
lifileucel (1)
ATL 001 (0)
BNT221 (0)
C-TCR055 (0)
CYAD-01 (0)
CoTIL-01 (0)
H3.3K27M TCR T cell therapy (0)
IOV-2001 (0)
NeoTCR-P1 (0)
OBX-115 (0)
RAPA-201 (0)
allodepleted T-cell immunotherapeutics (0)
UTIL-01 (0)
anti-KRAS G12D mTCR PBL (0)
marrow infiltrating lymphocytes (0)
MT-401 (0)
CAR-T19/CAR-T22 immunotherapy (1)
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR (0)
4SCAR-T (0)
AUTO1/22 (0)
AUTO3 (0)
Anti-CD19/CD20/CD22 CAR T-Cells (0)
Anti-CD22 CAR-T Cells (0)
CAR-T CD19/CD20/CD22/CD30 (0)
CAR20.19.22 T (0)
CART-19/22 (0)
CART22 (0)
CART22 (0)
CD19 and CD22 targeted prime CAR-T (0)
CD19-CD22 CAR-T (0)
CD19/CD22 CAR T-cells (0)
CD19/CD22 CAR-T cell therapy (0)
CD19/CD22 chimeric antigen receptor T cell (0)
CD19/CD22 dual-target CAR-T (0)
CD19x22 CAR T (0)
CD22-CART (0)
CD22-targeted CAR-T cell therapy (0)
CD22/CD19 CAR T (0)
CT120 (0)
CTA101 (0)
GC022F (0)
HY004 (0)
IMJ995 (0)
JCAR018 (0)
LB1909 (0)
LCAR-AIO (0)
MB-CAR-T19-22 (0)
SCRI-CAR19x22v2 (0)
SCRI-CAR22v2 (0)
Senl_22 (0)
Senl_H19x22P (0)
UCART20x22 (0)
UCART22 (0)
anti-CD19/CD22 CAR-T cells (0)
anti-CD22 CAR T (0)
anti-CD22 CAR-T cell therapy (0)
anti-CD22 CAR-T therapy (0)
anti-CD22-CAR (0)
autologous TriCAR T (0)
CRG-022 (0)
multi-CAR-T cell therapy (0)
multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)
sequential different B cell antigen-targeted CAR T-cell therapy (0)
lifileucel (1)
ATL 001 (0)
BNT221 (0)
C-TCR055 (0)
CYAD-01 (0)
CoTIL-01 (0)
H3.3K27M TCR T cell therapy (0)
IOV-2001 (0)
NeoTCR-P1 (0)
OBX-115 (0)
RAPA-201 (0)
allodepleted T-cell immunotherapeutics (0)
UTIL-01 (0)
anti-KRAS G12D mTCR PBL (0)
marrow infiltrating lymphocytes (0)
MT-401 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login